An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease.
第一作者:
Christina,Dold
第一单位:
Oxford Vaccine Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, CCVTM, Churchill Lane, Oxford OX3 7LE, UK.
作者:
主题词
人类(Humans);小鼠(Mice);动物(Animals);补体因子H(Complement Factor H);脑膜炎双球菌菌苗(Meningococcal Vaccines);脑膜炎奈瑟球菌, 血清B群(Neisseria meningitidis, Serogroup B);抗原, 细菌(Antigens, Bacterial);细菌蛋白质类(Bacterial Proteins);脑膜炎双球菌感染(Meningococcal Infections);脑膜炎奈瑟球菌(Neisseria meningitidis);载体蛋白质类(Carrier Proteins);小鼠, 转基因(Mice, Transgenic);病毒疫苗(Viral Vaccines);腺病毒科(Adenoviridae);抗体, 细菌(Antibodies, Bacterial)
DOI
10.1126/scitranslmed.ade3901
PMID
37343082
发布时间
2024-03-20
- 浏览2

Science translational medicine
eade3901页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文